A Rapport Therapeutics director's funds buy $20.4 million of shares
Director James Healy, through Sofinnova funds, bought $20.4 million of Rapport Therapeutics shares at $21 on October 28, and the purchases were filed on October 30.
The purchases
1 insider
Purchase on Oct 28, filed on Oct 30
1
Buyer
$20.36M
Bought
0
Sellers
Director
JH
James Healy
Buy · $20.36M · 969,480 shares
+52.0%
On the right, by how much each one increased the number of shares they own. Purchases declared to the SEC, the US stock market watchdog (Form 4), decided on the spot and not scheduled in advance.
AI analysis
Oct 30
With TrueWallet Pro
Why these purchases matter given where the stock stands, and what they do not say. Upgrade to Pro from the TrueWallet app.